Φορτώνει......
Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer
OBJECTIVE: In this study, we evaluated the toxicity and clinical efficacy of nivolumab, a programmed cell death protein 1 (PD-1) inhibitor, on patients with platinum resistant ovarian cancer. METHODS: Every second week, 18 patients with platinum resistance ovarian cancer received nivolumab until dis...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Gynecol Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543107/ https://ncbi.nlm.nih.gov/pubmed/31074244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2019.30.e56 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|